Spencer S. Lee Sells 732 Shares of Chemed Co. (NYSE:CHE) Stock

Chemed Co. (NYSE:CHE) EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Chemed Price Performance

Shares of CHE stock opened at $572.39 on Friday. The company has a market cap of $8.61 billion, a PE ratio of 28.92, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The stock’s 50 day simple moving average is $578.27 and its two-hundred day simple moving average is $565.09.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.32 EPS. Equities research analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s dividend payout ratio is presently 10.11%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday. Royal Bank of Canada dropped their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Hedge Funds Weigh In On Chemed

Several hedge funds have recently added to or reduced their stakes in CHE. GAMMA Investing LLC lifted its stake in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the last quarter. American National Bank & Trust purchased a new stake in shares of Chemed in the third quarter worth approximately $61,000. Mather Group LLC. lifted its stake in shares of Chemed by 60.5% during the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after acquiring an additional 69 shares during the last quarter. Quarry LP boosted its holdings in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares during the period. Finally, Sound Income Strategies LLC purchased a new position in Chemed during the 3rd quarter valued at $201,000. 95.85% of the stock is currently owned by institutional investors.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.